Annotation Detail for XYLT1
Basic Information
Top
Pathway ID | Pathway Name |
---|
PWY-6564 | heparan sulfate biosynthesis |
PWY-6569 | chondroitin sulfate biosynthesis |
PWY-6571 | dermatan sulfate biosynthesis |
PWY-6557 | glycoaminoglycan-protein linkage region biosynthesis |
Pathway ID | Pathway Name |
---|
hsa00534 | Glycosaminoglycan biosynthesis - heparan sulfate |
hsa00532 | Glycosaminoglycan biosynthesis - chondroitin sulfate |
hsa01100 | Metabolic pathways |
Desease ID | Desease Name |
---|
1904 | Diabetes mellitus |
2156 | Pseudoxanthoma elasticum |
2256 | Aortic aneurysm |
Desease Name |
---|
diabetic nephropathy |
RENAL |
Desease Name |
---|
Pseudoxanthoma elasticum, modifier of severity of |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of XYLT1 mRNA | affects expression | 17562736
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of XYLT1 mRNA | affects expression | 16483693
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of XYLT1 mRNA | affects expression | 20382639
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
4.30 | 18287403 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
4.71 | 10982225 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.39 | 18445737 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
1.41 | 3084413 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.81 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
3.01 | 20889678 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
1.68 | 16485898 12540782 16109766 11743745 14986274 19416960 19164858 18713872 17562736 14550746 16227642 16781746 12594235 11461765 19739265 14725611 16081117 12153990 10915739 11529661 10774834 11739529 11287661 12705907 16393943 16177239 12392966 17522070 15968718 19085960 15619225 12958197 17906064 19420014 11834606 10663392 11421492 2444490 19923254 19370779 18071297 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.96 | 19426721 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.15 | 20426865 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
4.54 | 16983495 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
3.06 | 16870215 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
2.42 | 15629191 12587719 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.71 | 19014921 16611625 19460945 12969438 11587558 19784758 12587719 16610002 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.68 | 16871587 17185352 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
4.22 | 19513568 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
3.26 | 18514411 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.77 | 16870215 |
MESH:D011561 |
Pseudoxanthoma Elasticum |
marker/mechanism |
|
| |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.50 | 10982225 |
Pathway ID |
Pathway Name |
---|
KEGG:00532 |
Glycosaminoglycan biosynthesis - chondroitin sulfate |
KEGG:00534 |
Glycosaminoglycan biosynthesis - heparan sulfate |
KEGG:01100 |
Metabolic pathways |